Sleep Apnea: The Diagnosis You Might Have and Not Know It

Thirty million Americans have obstructive sleep apnea. Most of them don't know it.

That number — from the American Academy of Sleep Medicine — represents one of the largest undiagnosed disease burdens in American medicine. We are not talking about a condition with subtle downstream effects. Untreated sleep apnea raises cardiovascular risk, accelerates metabolic dysfunction, impairs cognitive performance, and — as I described in the glymphatic post — directly impairs the brain's nightly waste-clearance system in a way that increases Alzheimer's risk. This is a condition with a clear, treatable mechanism that most people affected by it have never been told they have.

The reason for the diagnostic gap comes down to who we think gets sleep apnea — and that picture is incomplete in ways that leave millions of people, particularly women, without a diagnosis for years.

The Classic Picture — and Why It Misses Most Patients

The textbook sleep apnea patient is an overweight, middle-aged man who snores loudly and whose bed partner has witnessed him stop breathing at night. He wakes unrefreshed, is sleepy during the day, and may fall asleep at red lights. This presentation is real, and it is the one that generates referrals.

But it describes a subset. Young, normal-weight adults get sleep apnea. People who do not snore loudly get sleep apnea. And women get sleep apnea — at rates that are dramatically underrecognized.

Young et al. (1993, *New England Journal of Medicine*, PMID 8464434) — the foundational Wisconsin Sleep Cohort study — estimated that 24% of men and 9% of women between 30 and 60 had at least mild sleep-disordered breathing. Those numbers have likely increased with rising obesity rates. More recent data from Heinzer et al. (2015, *Lancet Respiratory Medicine*, PMID 25682233) using modern AHI criteria found prevalence of 49.7% in men and 23.4% in women in a general adult population — staggeringly high.

Women Are Systematically Underdiagnosed

The underdiagnosis of sleep apnea in women is one of the more consequential blind spots in modern medicine. Wimms et al. (2016, *ERJ Open Research*, PMID 27699167) reviewed the evidence and found that women present with different and often subtler symptoms than men: fatigue and insomnia (rather than witnessed apneas), morning headaches, mood disturbance, anxiety, and depression — symptoms that are frequently attributed to hormonal fluctuation, depression, or stress rather than disordered breathing.

Women are also less likely to have bed partners who report witnessed apneas (often because they sleep alone, or because female apneas tend to be shorter and less dramatic). The combination of atypical presentation and referral bias means women wait significantly longer for diagnosis — and are more likely to be prescribed antidepressants or sleep medications before anyone orders a sleep study.

Menopause significantly increases risk. Postmenopausal women have sleep apnea prevalence approaching that of age-matched men, driven by loss of progesterone (which has respiratory stimulant effects) and redistribution of body fat. If you are a woman in perimenopause or menopause with new-onset fatigue, insomnia, or poor sleep quality — sleep apnea belongs on the differential.

The STOP-BANG Screening Tool

STOP-BANG is a validated eight-question screening tool that takes two minutes to complete. Chung et al. (2008, *Anesthesiology*, PMID 18431116) validated it in surgical patients with a sensitivity of 93% for moderate-to-severe OSA at a score of ≥3.

S — Do you Snore loudly? T — Do you often feel Tired, fatigued, or sleepy during the daytime? O — Has anyone Observed you stop breathing during sleep? P — Do you have or are you being treated for high blood Pressure? B — BMI greater than 35? A — Age greater than 50? N — Neck circumference greater than 40 cm (about 15.7 inches)? G — Gender male?

Score 0–2: low risk. Score 3–4: intermediate risk. Score 5–8: high risk. Three or more is the threshold for clinical concern. Note that being female actually works against your score — which is one of the structural reasons the tool underestimates risk in women.

If you score 3 or above, that is a conversation with your physician and likely a sleep study.

What Untreated OSA Does to Your Body

The downstream consequences of untreated sleep apnea are not subtle or long-term in an abstract sense — they are happening continuously, every night.

Cardiovascular: Each apneic event triggers a surge of sympathetic nervous system activation, cortisol, and catecholamines as the brain forces arousal to restart breathing. Multiply that by hundreds of times per night, every night. Gottlieb et al. (2010, *Circulation*, PMID 20625114) demonstrated that severe OSA is associated with a significantly elevated risk of incident atrial fibrillation, heart failure, coronary artery disease, and stroke. The Sleep Heart Health Study found OSA independently predicted cardiovascular events after controlling for traditional risk factors.

Metabolic: Intermittent hypoxia and sleep fragmentation impair insulin sensitivity. Punjabi et al. (2004, *American Journal of Respiratory and Critical Care Medicine*, PMID 15353412) documented glucose dysregulation proportional to OSA severity, independent of obesity. OSA makes metabolic syndrome worse and harder to treat.

Cognitive and neurodegenerative: Sleep fragmentation from apnea directly impairs glymphatic clearance — the brain's nightly waste-removal system — preventing adequate clearance of beta-amyloid and tau. Sharma et al. (2018, *Annals of the American Thoracic Society*, PMID 29125327) found higher amyloid burden in OSA patients. Importantly, Ancoli-Israel et al. demonstrated CPAP treatment over time reduces amyloid markers — meaning this is reversible.

Testing Is Now Accessible

A full in-lab polysomnography is no longer the only path to diagnosis. Home sleep apnea testing (HSAT) devices — worn at home for one or two nights — are now validated, insurance-covered in most cases, and appropriate for most patients with intermediate-to-high STOP-BANG scores who do not have significant comorbidities (severe heart failure, suspected central apnea, or hypoventilation syndromes warrant full PSG).

The American Academy of Sleep Medicine endorses HSAT as an appropriate diagnostic tool for uncomplicated OSA. Portability removed a major barrier: patients no longer need to sleep in a lab to get a diagnosis.

Treatment — CPAP and Beyond

CPAP (continuous positive airway pressure) is the gold standard. It works by delivering pressurized air through a mask that acts as a pneumatic splint, holding the upper airway open throughout the sleep cycle. The evidence for CPAP reducing cardiovascular events, improving metabolic markers, and improving neurocognitive function is robust. Compliance is the bottleneck — historically 30–50% of patients are non-adherent within the first year.

Modern CPAP machines are substantially better than the devices of a decade ago: quieter, smaller, heated humidifiers, auto-titrating pressure (APAP), and data connectivity so providers can monitor compliance and efficacy remotely.

For patients who cannot tolerate CPAP: - Mandibular advancement devices (MADs): custom oral appliances that advance the jaw to open the airway. Less effective than CPAP for severe OSA but acceptable for mild-to-moderate and CPAP-intolerant patients. - Positional therapy: a subset of OSA is position-dependent (supine position only). Lateral sleep positioning significantly reduces AHI in these patients. - Inspire (hypoglossal nerve stimulator): an implanted device that stimulates the hypoglossal nerve to advance the tongue during sleep. FDA-approved for CPAP-intolerant patients with moderate-to-severe OSA. Remarkable technology for the right patient. - Weight loss: significant weight loss can reduce or resolve OSA; however, it cannot be the only intervention while OSA is causing harm.

I've been amazed at the number of positive sleep studies we get. We order them on most people who have hypertension, fatigue, or obesity. And the severity of the sleep disturbances is what's really eye catching. Some people stop breathing hundreds of times per night! No wonder they feel so bad! And it's sad to say that even in our modern times, we still don't consider women for sleep studies as often as men. I examine the throat on everyone, just a habit from the old days of medicine when we actually examined people, and I am shocked how many healthy young people have large tonsils, large tongues, or just small throat openings. This is what leads to sleep apnea in otherwise healthy women.

The Bottom Line

If you snore, wake unrefreshed, feel tired despite adequate sleep time, have been told you stop breathing at night, or have a STOP-BANG score of 3 or more: get tested. Home sleep testing has eliminated the logistical barriers. This is not optional from a longevity standpoint.

Treating sleep apnea is not just about feeling less tired. It is about removing a continuous cardiovascular and neurodegenerative insult that is accumulating damage every night. The intervention is effective. The data is unambiguous. The only thing standing between most undiagnosed patients and a treatment that would meaningfully change their long-term health trajectory is the conversation.

*This is not medical advice. I'm sharing clinical evidence and framework to help you have better conversations with your provider.*